is tirzepatide a glp 1 or glp 2 Understand GLP-1/GIP Dual Agonist and Its Effect on Current Weight Loss Therapy Tirzepatide vs. Semaglutide: Key Differences

Is a video visit required to get started

The most commonly reported adverse events (observed in greater than 5% of clinical trial participants) were nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection-site reactions, fatigue, hypersensitivity reactions, eructation, hair loss and gastroesophageal reflux disease

Clinicians should remain attentive to forthcoming trial data that may guide integration of GLP-1 and dual agonists into standard care

Your licensed provider will design a tirzepatide treatment plan tailored to your needs

This is especially important since Ozempic slows digestion, giving your body more time to absorb water from your bowels

Both medications provide lasting results Because semaglutide often works faster, its the preferred option for GLP-1 patients